GLUCOCORTICOID DOSE IS PROGRESSIVELY REDUCED IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) RECEIVING SARILUMAB: RESULTS FROM THE OPEN LABEL EXTEND STUDY

被引：0

作者：

Fleischmann, Roy ^{[1
]}

Selmi, Carlo ^{[2
]}

Angel Gonzalez-Gay, Miguel ^{[3
,4
]}

van Hoogstraten, Hubert ^{[5
]}

Hagino, Owen ^{[6
]}

Rajput, Tejasweeni ^{[7
]}

St John, Gregory ^{[8
]}

Buttgereit, Frank ^{[9
]}

Genovese, Mark C. ^{[10
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA

[2] Humanitas Clin & Res Ctr, Div Rheumatol & Clin Immunol, Milan, Italy

[3] Univ Cantabria, Santander, Spain

[4] Hosp Univ Marques Valdecilla, IDIVAL, Santander, Spain

[5] Sanofi, Global Med Affairs, Bridgewater, NJ USA

[6] Sanofi, Immunol & Inflammat Dev Unit, Bridgewater, NJ USA

[7] Cytel, Biostat, Mumbai, Maharashtra, India

[8] Regeneron Pharmaceut Inc, Immunol & Inflammat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[9] Charite Univ Med Berlin, Rheumatol & Clin Immunol, Berlin, Germany

[10] Stanford Univ, Div Immunol, Palo Alto, CA 94304 USA

来源：

RHEUMATOLOGY | 2020年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P235

引用

页码：108 / 108

页数：1

共 50 条

[1] GLUCOCORTICOID DOSE IS PROGRESSIVELY REDUCED IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING SARILUMAB: RESULTS FROM THE OPEN-LABEL EXTEND STUDY
Fleischmann, Roy
Selmi, Carlo
Gonzalez-Gay, Miguel Angel
van Hoogstraten, Hubert
Hagino, Owen
Rajput, Tejasweeni
St John, Gregory
Buttgereit, Frank
Genovese, Mark C.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 80 - 80
[2] Glucocorticoid Dose Is Progressively Reduced in Patients with RA Receiving Sarilumab: Results from the Open-Label EXTEND Study
Fleischmann, Roy
Selmi, Carlo
Gonzalez-Gay, Miguel Angel
van Hoogstraten, Hubert
Hagino, Owen
Rajput, Tejasweeni
St John, Gregory
Buttgereit, Frank
Genovese, Mark
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[3] SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RHEUMATOID ARTHRITIS PATIENTS
Genovese, Mark C.
Fay, Jon
Parrino, Janie
Beyer, Doris
Iglesias-Rodriguez, Melitza
Graham, Neil
Boddy, Alex
Martincova, Renata
Burmester, Gerd R.
RHEUMATOLOGY, 2017, 56 : 139 - 139
[4] Sarilumab Dose Reduction in an Open-Label Extension Study in RA Patients
Genovese, Mark C.
Fay, Jon
Parrino, Janie
Beyer, Doris
Iglesias-Rodriguez, Melitza
Graham, Neil
Boddy, Alex
Simon, J-Abraham
Martincova, Renata
Burmester, Gerd R.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[5] Sarilumab Dose Reduction in an Open-label Extension Study in RA Patients
Genovese, Mark
Fay, Jonathan
Parrino, Janie
Beyer, Doris
Iglesias-Rodriguez, Melitza
van Hoogstraten, Hubert
Graham, Neil
Boddy, Alex
Simon, Abraham
Martincova, Renata
Burmester, Gerd
Fiore, Stefano
JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 895 - 896
[6] SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS
Genovese, M. C.
Fay, J.
Beyer, D.
Iglesias-Rodriguez, M.
Simon, A.
Martincova, R.
Burmester, G. R.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S69 - S70
[7] SARILUMAB DOSE REDUCTION TO MANAGE LABORATORY ABNORMALITIES IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS
Genovese, M. C.
Fay, J.
Parrino, J.
Garg, A.
Van Hoogstraten, H.
Boddy, A.
Martincova, R.
Graham, N.
Simon, J.
Burmester, G. R.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 515 - 516
[8] Sarilumab Dose Reduction to Manage Laboratory Abnormalities in an Open-Label Extension Study in RA Patients
Burmester, Gerd
Garg, Anju
van Hoogstraten, Hubert
Graham, Neil
Boddy, Alex
Parrino, Janie
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[9] SARILUMAB DOSE REDUCTION TO MANAGE LABORATORY ABNORMALITIES IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS
Burmester, Gerd R.
Garg, Anju
Van Hoogstraten, Hubert
Graham, Neil
Boddy, Alexander
Parrino, Janie
Genovese, Mark C.
INTERNAL MEDICINE JOURNAL, 2016, 46 : 40 - 41
[10] Patient-Reported Benefits of Sarilumab Monotherapy in Adult Patients with Active Rheumatoid Arthritis: Results from an Open-Label Extension Study
Strand, Vibeke
Reaney, Matthew
Mangan, Erin
van Hoogstraten, Hubert
Boklage, Susan
Hu, Chih-Chi
ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →